Ctrl/Cmd K

Loading stock analysis…

Explore

Stocks
Screener
IPOs
News

Tools

Backtest
Portfolio
Wealth
ITR

Learn

Guides
Methodology

Company

About
Contact
Disclosures
Privacy
Terms

© 2026 Anvest. All rights reserved.

Designed & Engineered in India·harsh@anvest.in

Disclaimer: Anvest provides financial analytics, screening simulations, and planning tools for informational and educational purposes only. Anvest is not a SEBI-registered investment advisor or broker. Nothing herein constitutes investment advice or an offer to buy/sell securities. Full details on methodology and limitations are documented under Disclosures and Terms.

Stocks›Healthcare

Caplin Point Laboratories Limited

CAPLIPOINT · NSE · Healthcare · As of 30 Oct 2026Delayed / Sandbox EOD Data

₹2,325.60

−₹50.50 (−2.13%)(1D)

₹1,500.3052 Week Range₹2,990.00

Chart Score AI Profile Fundamentals Technicals Financials Shareholding Peers Filings

Anvest Score

79/100

Valuation

55/100

Quality

85/100

Growth

86/100

Health

100/100

Momentum

69/100

Valuation
55
Quality
85
Growth
86
Health
100
Momentum
69

Loading company profile…

Loading fundamentals…

Loading technical indicators…

Loading financial statement…

Loading shareholding…

Loading peer comparison…

Loading filings…

More Page Context

Research at a glance

Caplin Point Laboratories Limited with delayed price, financials, ownership context, and peer links.

Latest price

₹2,325.6

Market cap

₹17,677 Cr

P/E ratio

26.57

P/B ratio

4.93

Dividend yield

Not available

ROE

Not available

RSI 14

40.08

1Y return

Not available

Caplin Point Laboratories Limited FAQs

3 topics

ExpandCollapse

Related paths

Peer links appear when comparable names are available.

Open screener Curated screens Backtest ideas

What does the Caplin Point Laboratories Limited (CAPLIPOINT) stock page cover?

Caplin Point Laboratories Limited on Anvest includes delayed price context, valuation ratios, a one-year price range, and section-level research data when available.

What are the current headline metrics for CAPLIPOINT?

Caplin Point Laboratories Limited is currently shown with a delayed price near ₹2,325.6, P/E 26.57.

Does the CAPLIPOINT page provide investment advice?

No. The CAPLIPOINT page is built for research, comparison, and planning. It does not publish buy, sell, or hold recommendations.

Keep exploring

Related insights

ALIVUS

Alivus Life Sciences Limited · Healthcare

COHANCE

Cohance Lifesciences Limited · Healthcare

SHILPAMED

Shilpa Medicare Limited · Healthcare

How to Analyze NSE/BSE Concall Transcripts & Management Guidance Using AI

Learn how specialized financial AI analyzes Indian company concalls, extracts capex and margin guidance, and tracks executive promises on Anvest.

AI Company ProfileSign in to generate AI briefing

AI Snapshot

Caplin Point Laboratories Limited manufactures and sells pharmaceuticals and finished dose formulations, contributing 100% of its turnover. The company operates manufacturing units and R&D centers nationally, with international offices.

Drug Manufacturers - Specialty & GenericFounded:1990CEO/MD:C. C. PaarthipanHQ:Chennai, Tamil Nadu

Business at a Glance

International operations and offices are not included in this reporting.

What Looks Strong

Financial highlights are being recalculated.

What to Watch

Financial highlights are being recalculated.

Revenue by geography, FY26 (consolidated, as filed): Rest of the World 79%; USA 21%.
The company generates revenue by developing, manufacturing, and marketing a diverse portfolio of generic and specialty pharmaceutical formulations.
It primarily sells these products through exports to underserved markets, leveraging its cost-effective production capabilities.